Clin2
NCT06170970Possibly a fitRecruiting

Solriamfetol for fatigue in multiple sclerosis

Multiple SclerosisMultiple Sclerosis Fatigue

Treatments studied

Part of Brain & nervous system, Immune system & allergy, Mental health clinical trials.

This study tests whether solriamfetol, a medication that promotes wakefulness, can reduce fatigue in people with multiple sclerosis. If you struggle with tiredness and sleepiness, this trial may help you understand how this drug works for MS-related fatigue.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
46 people
Ages
18 years to 60 years
Study type
Interventional

Who can take part

  • Be between 18 and 60 years old
  • Have a diagnosis of multiple sclerosis (MS) and fatigue as a main symptom
  • Feel very sleepy during the day (score 10 or more on a sleepiness scale)
  • Be able to walk at least 20 feet with help from a cane, walker, or other device
  • Have access to internet and email, and own a smartphone (Android or iPhone)

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06441617Enrolling by invitation
Online program to reduce fatigue in multiple sclerosis

This trial tests an online self-management program to help reduce fatigue in people with MS. You'll use a website or app over 24 weeks, and researchers will check how well it works.

Washington D.C., District of Columbia
NCT06386133Not yet recruiting
Smartphone app for fatigue in multiple sclerosis

This study tests a smartphone app called MS Copilot Boost that aims to help reduce fatigue in people with MS. You will use the app along with wearing a small wrist device, and we compare it with usual care to see if it improves fatigue.

NCT07438964Recruiting
Brain stimulation for MS fatigue

This study uses a safe, non-invasive brain stimulation technique to see if it can reduce fatigue in people with relapsing-remitting MS. It compares people with and without fatigue to understand how the brain is affected.

Berlin, State of Berlin
NCT07842302Not yet recruiting
Brain stimulation for fatigue in multiple sclerosis

This study tests two non-invasive brain stimulation treatments—TMS and tDCS—to see if they can reduce fatigue in people with relapsing-remitting MS. The goal is to find a safe, drug-free way to help you feel less tired.

NCT07310862Not yet recruiting
Virtual reality light and sound therapy for fatigue in MS

This trial tests a virtual reality headset that delivers light and sound stimulation to see if it can reduce tiredness in people with multiple sclerosis. If you struggle with fatigue, this therapy might offer a new drug-free way to feel more energetic.

Barcelona, Barcelona
NCT07426991Recruiting
Multiple sclerosis, thinking, sleep, and tiredness study

This study looks at how multiple sclerosis (MS) affects your thinking, sleep, and tiredness. It compares people with MS who have at least mild fatigue to people without MS who also have sleep problems, to understand these issues better.

Düsseldorf

Hear when a new Multiple sclerosis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.